TABLE 4.
Uni- and multivariate logistic regression analysis of factors associated with pneumococcal vaccination among non-vaccinated patients (n = 1,111) during follow-up.
| Variable | Univariate | Multivariate | ||||
| OR | 95% CI | P | OR | 95% CI | P | |
| Age, per 10 years | 1.24 | 1.13–1.37 | <0.001 | 1.08 | 0.94–1.24 | 0.27 |
| Sex (male) | 0.86 | 0.63–1.15 | 0.31 | 0.65 | 0.43–0.99 | 0.045 |
| RF and/or anti-CCP positivity | 1.29 | 1.006–1.65 | 0.045 | 1.47 | 1.05–2.05 | 0.023 |
| bDMARD use at baseline | 1.56 | 1.22–2.00 | <0.001 | 1.85 | 1.29–2.65 | 0.001 |
| DAS28-ESR at baseline | 1.31 | 1.18–1.44 | <0.001 | 1.33 | 1.17–1.51 | <0.001 |
| Dyslipidemia | 1.29 | 0.99–1.66 | 0.056 | 1.15 | 0.80–1.65 | 0.44 |
| COPD and/or RA-ILD | 2.32 | 1.38–3.92 | 0.002 | 1.90 | 0.87–4.13 | 0.10 |
| History of cancer | 1.54 | 0.95–2.48 | 0.077 | 2.35 | 1.09–5.06 | 0.03 |
| ≥1 influenza vaccination during follow-up | 6.28 | 5.05–7.81 | <0.001 | 33.35 | 18.58–59.85 | <0.001 |
Statistically significant values with a p-value <0.05 are shown in italics.